2025 Neuroimaging Reading List

Reading List

Please click below to access the 2025 Neuroimaging reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Analyze amyloid- and tau-related imaging to infer correct diagnosis in common neurodegenerative disorders
• Identify nuances on neuroimaging that help to distinguish among various neuroinflammatory disease states
• Identify changes in resting-state functional brain activity among pediatric concussion patients
• Describe the benefits of advanced neuroimaging techniques as a potential aid in predicting outcomes in atherosclerotic patients

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry and Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved this activity as part of a comprehensive self-assessment (SA) CME activity, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of continuing certification.

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2025 C-cert Activity Planner (Certification Council) Disclosures
All relevant financial relationships have been mitigated.

Neuroimaging Certification Examination Committee Contributors

Jennifer Williams McVige, MD, Chair, Dent Neurologic Institute 
Disclosures: Received compensation for consulting work for Abbvie, Neurelis, and Otsuka; received compensation for serving on advisory boards for Abbvie, Neurelis, and Otsuka; receive compensation for serving on speakers bureaus for Abbvie, Neurelis, and Otsuka; received compensation from ABPN for flights and hotel. Receives compensation when periodically (1-2 times/year) serving as an expert witness for head trauma cases. Currently running research studies for many pharmaceutical companies and has a grant from the Dent family foundation to run personal research. Grant money is used to pay for research assistance; serves as a consultant for the ABPN for their neuroimaging exam questions, making sure that the neuroimaging is up-to-date and appropriate. 

Gregory Kapinos, MD, MS, HEC-C, Vice Chair, NYC Health + Hospitals/Elmhurst 
Disclosures: Nothing to disclose. 

Madhureeta Achari, MD, Integrated Neurology, PA 
Disclosures: Received compensation from Lilly Advisory Board x 2 in 2023 and 2024; received consultation compensation from Lilly Advisory board as above. Not ongoing; has served as expert witness for multiple law firms. 

Carmel Armon, MD, MHS, Shamir (Assaf Harofeh) Medical Center, Israel  
Disclosures: Receives compensation as Associate Editor, Journal of Neurological Sciences; received compensation as expert witness from Inbal Insurance company, Inc - Neurological consultant in personal injury cases for various attorneys - Neurological consultant in personal injury cases as court-appointed expert - Neurological consultant in personal injury and competency cases; receives royalties for co-authoring UpToDate chapters. 

John A. Bertelson, MD, Texas Tech School of Medicine 
Disclosures: Received compensation from Eisai for speakers bureau; received compensation from numerous law firms, self, expert witness; Immediate past president, self, IAC-MRI Board; own multiple stocks, none related to Neuroimaging. 

Dimitrios Giannakidis, MD, Sutter West Bay Medical Group 
Disclosures: Nothing to disclose.

Mohammad Obadah Nakawah, MD, Houston Methodist Neurological Institute  
Disclosures: Nothing to disclose. 

Gustavo J. Rodriguez, MD, Texas Tech Physicians of El Paso 
Disclosures: Nothing to disclose. 

Oana Dumitrascu, MD, MS, Mayo Clinic - Scottsdale 
Disclosures: Nothing to disclose. 

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326